Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-02-23 @ 3:01 PM
Study NCT ID:
NCT01605032
Status:
COMPLETED
Last Update Posted:
2020-08-20
First Post:
2012-03-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma
Sponsor:
Albert Einstein College of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11-12-434
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |